We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$16.2B
AUM Growth
+$1.63B
Cap. Flow
+$894M
Cap. Flow %
5.51%
Top 10 Hldgs %
15.16%
Holding
2,286
New
215
Increased
1,251
Reduced
646
Closed
120

Sector Composition

Rank Sector Weight
1 Energy 9.92%
2 Technology 7.94%
3 Healthcare 7.8%
4 Financials 7.55%
5 Industrials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESRX
101
DELISTED
Express Scripts Holding Company
ESRX
$29.4M 0.18%
424,002
+52,300
+14% +$3.68M
BAC icon
102
Bank of America
BAC
$438B
$29.3M 0.18%
1,909,505
-537,727
-22% -$8.35M
NOV icon
103
NOV
NOV
$6.94B
$29.3M 0.18%
356,092
+74,042
+26% +$5.51M
CMCSK
104
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$29.1M 0.18%
545,908
+58,943
+12% +$3.14M
NFG icon
105
National Fuel Gas
NFG
$7.87B
$29M 0.18%
370,810
+19,675
+6% +$1.45M
FXH icon
106
First Trust Health Care AlphaDEX Fund
FXH
$1.06B
$28.7M 0.18%
539,202
-11,381
-2% -$578K
PDP icon
107
Invesco Dorsey Wright Momentum ETF
PDP
$1.47B
$28.5M 0.18%
729,801
-32,657
-4% -$1.23M
SJNK icon
108
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.74B
$28.2M 0.17%
912,251
+121,462
+15% +$3.75M
SYY icon
109
Sysco
SYY
$40.7B
$28M 0.17%
747,720
-1,637
-0.2% -$60.1K
FBT icon
110
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.71B
$27.9M 0.17%
338,379
+34,308
+11% +$2.62M
APC
111
DELISTED
Anadarko Petroleum
APC
$27.8M 0.17%
253,869
-4,329
-2% -$441K
HAL icon
112
Halliburton
HAL
$26.6B
$27.7M 0.17%
390,200
+82,917
+27% +$5.31M
WMT icon
113
Walmart Inc
WMT
$881B
$27.7M 0.17%
1,106,367
-106,113
-9% -$2.73M
UL icon
114
Unilever
UL
$137B
$27.4M 0.17%
537,760
+171,869
+47% +$8.61M
MWE
115
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
$26.9M 0.17%
375,118
+12,665
+3% +$816K
AMZN icon
116
Amazon
AMZN
$3.06T
$26.8M 0.17%
1,651,060
+60,640
+4% +$959K
WPZ
117
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
$26.7M 0.16%
521,117
+45,193
+9% +$2.23M
FRX
118
DELISTED
FOREST LABORATORIES INC
FRX
$26.5M 0.16%
268,102
+32,136
+14% +$3M
TGT icon
119
Target
TGT
$67.8B
$26.3M 0.16%
453,951
+59,058
+15% +$3.47M
TFC icon
120
Truist Financial
TFC
$63.4B
$26.1M 0.16%
663,195
+9,790
+1% +$375K
RTX icon
121
RTX Corp
RTX
$292B
$26M 0.16%
358,243
+30,065
+9% +$2.21M
ADP icon
122
Automatic Data Processing
ADP
$107B
$25.9M 0.16%
372,007
+18,153
+5% +$1.24M
CELG
123
DELISTED
Celgene Corp
CELG
$25.4M 0.16%
295,439
+54,195
+22% +$4.12M
ENLK
124
DELISTED
EnLink Midstream Partners, LP
ENLK
$25.4M 0.16%
806,809
+12,913
+2% +$395K
MMM icon
125
3M
MMM
$91.4B
$25.3M 0.16%
210,882
+16,935
+9% +$1.99M

Similar funds

Raymond James & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Raymond James & Associates held 2,286 positions worth $16.2B, up 11% from $14.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $894M of net new capital in Q2 2014, opening 215 new positions and adding to 1,251 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.

By sector, the portfolio is most concentrated in Energy at 9.9% of assets, up from 9.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was AstraZeneca, an estimated $38.6M trimmed.

  • Raymond James & Associates's largest Q2 2014 buy was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.
  • Raymond James & Associates added most to iShares MSCI EAFE ETF in Q2 2014, an estimated $38.2M increase.
  • Raymond James & Associates's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $38.6M.
  • Raymond James & Associates fully exited Weatherford International plc in Q2 2014, selling an estimated $20.6M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $16.2B portfolio in Q2 2014.
  • Raymond James & Associates opened 215 new positions and closed 120 in Q2 2014.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $16.2B.

Based on Raymond James & Associates's 13F filing for Q2 2014, filed 13 Aug 2014.